Algorhythm Holdings Inc
Filed Oct 3, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Oct 3, 2025
Contents
Cover page
Show cover page
Registration No. 333-[●]
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORMS-1
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
ALGORHYTHM HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 3652 | 95-3795478 |
|---|---|---|
| (State or Other Jurisdiction of Incorporation or Organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification No.) |
6301 NW 5th Way, Suite 2900
Fort Lauderdale, FL 33309
(954) 596-1000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Gary Atkinson
Chief Executive Officer
6301 NW 5th Way, Suite 2900
Fort Lauderdale, FL 33309
(954) 596-1000
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Gregory Sichenzia, Esq.
Marcelle S. Balcombe, Esq.
Sichenzia Ross Ference Carmel LLP
1185 Avenue of the Americas, 31 st Floor
New York, NY 10036
Telephone: (212) 930-9700
Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ |
|---|---|
| Non-accelerated filer ☒ | Smaller reporting company ☒ |
| Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission acting pursuant to said Section 8(a), may determine.
EXPLANATORY NOTE
This registration statement contains two prospectuses, as set forth below.
| ● | Resale Prospectus. A prospectus to be used for the resale by the selling stockholder (the “Selling Stockholder”) set forth in the section of the resale prospectus (the “Resale Prospectus”) entitled “Selling Stockholder” of up to 10,095,694 shares of common stock, $0.01 par value, of Algorhythm Holdings, Inc., a Delaware corporation (the “Company”). |
|---|
| ● | Public Offering Prospectus. A prospectus to be used for the public offering (the “Public Offering Prospectus”) of up to 1,133,652 shares of common stock issuable upon the exercise of outstanding Series A warrants (the “Series A Warrants”). |
|---|
The Public Offering Prospectus is substantively identical to the Resale Offering Prospectus, except for the following principal points:
| ● | they contain different outside and inside front covers and back covers; |
|---|
| ● | they contain different “Offering” summaries in the “Prospectus Summary” section; |
|---|---|
| ● | they contain different “Summary of the Offering” sections; |
| ● | within the “Risk Factors” sections, the “Risks Related to this Offering and the Selling Stockholder” and “Risks Related to the Transactions Under the Securities Purchase Agreement” sections have been deleted from the Public Offering Prospectus and a “Risks Related to This Offering” section has been added in their place in the Public Offering Prospectus; |
| ● | they contain different “Use of Proceeds” sections; |
|---|
| ● | a “Capitalization” section that does not appear in the Resale Prospectus has been added to the Public Offering Prospectus; |
|---|
| ● | the “Selling Stockholders” section has been removed from the Public Offering Prospectus; and |
|---|
| ● | the “Plan of Distribution” section from the Resale Prospectus has been deleted from the Public Offering Prospectus and a “Public Offering Plan of Distribution” has been added in its place in the Public Offering Prospectus. |
|---|
The Company has included in this registration statement a set of alternate pages after the back cover page of the Resale Prospectus (the “Alternate Pages”) to reflect the foregoing differences in the Public Offering Prospectus as compared to the Resale Prospectus. The Resale Prospectus will include the Alternate Pages and will be used for the resale of shares of common stock by the Selling Stockholder. The Public Offering Prospectus will be substantively identical to the Resale Prospectus except for the addition or substitution of the Alternate Pages, and such other changes as may be necessary to clarify references to the public offering or the resale offering and will be used for the public offering by the Company.
THE INFORMATION IN THIS PRELIMINARY PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. THESE SECURITIES MAY NOT BE SOLD UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS DECLARED EFFECTIVE. THIS PRELIMINARY PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND WE ARE NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE OR OTHER JURISDICTION WHERE THE OFFER OR SALE IS NOT PERMITTED.
| PRELIMINARY PROSPECTUS | SUBJECT TO COMPLETION | DATED OCTOBER [●], 2025 |
|---|
Resale of Up to 10,095,694 Shares of Common Stock
This prospectus relates to the resale of up to 10,095,694 shares of our common stock, par value $0.01 per share (the “common stock”), by Streeterville Capital, LLC, a Utah limited liability company (“Streeterville” or the “Selling Stockholder”), consisting of: (i) 95,694 shares of our common stock issued to Streeterville as a commitment fee for the pre-paid purchase facility established under that certain Securities Purchase Agreement, dated as of August 21, 2025, between Algorhythm Holdings, Inc. (the “Company”, the “registrant,” “we,” “our” or “us”) and Streeterville (the “Securities Purchase Agreement”), and (ii) up to 10,000,000 additional shares of our common stock that may be issued to Streeterville under the Securities Purchase Agreement.
Under the Securities Purchase Agreement, we may issue and sell to Streeterville shares of our common stock in one or more pre-paid purchases (each, a “Pre-Paid Purchase” and collectively, the “Pre-Paid Purchases”) for an aggregate purchase price of up to $20,000,000. Upon the terms and subject to the conditions of each Pre-Paid Purchase, following the funding of each Pre-Paid Purchase, Streeterville, in its sole discretion, has the right, but not the obligation, to purchase from us, and we will issue to Streeterville, shares of our common stock in satisfaction of all or a portion of the outstanding balance of the Pre-Paid Purchases, but not exceeding the outstanding balance of the Pre-Paid Purchases (the “Purchase Shares”). Any purchase of the 10,000,000 Purchase Shares registered for resale pursuant to the registration statement of which this prospectus is a part will reduce the outstanding balance of the Pre-Paid Purchases at a price per share that will fluctuate based on the trading price of our common stock during the applicable measuring period. The number of shares of common stock that may be issued to Streeterville is subject to certain conditions and limitations, including a limitation that Streeterville cannot beneficially own in excess of 9.99% of our outstanding shares of common stock and a restriction that we cannot issue shares of common stock to Streeterville in violation of Nasdaq Listing Rule 5635(d). The number of shares of common stock that may be acquired by Streeterville pursuant to the Securities Purchase Agreement is not currently known and is subject to satisfaction of certain conditions and other limitations, including the conditions and limitations described above.
We will not receive any proceeds from the sale or other disposition of shares by Streeterville. Streeterville will bear all commissions and discounts, if any, attributable to the sale or other disposition of the shares. We will bear all costs, expenses and fees incurred in connection with the registration of Streeterville’s shares.
The distribution of the shares of common stock offered hereby may be effected in one or more transactions that may take place in ordinary brokers’ transactions, privately negotiated transactions or through sales to one or more dealers for resale of such securities as principals.
Our common stock is listed on The Nasdaq Capital Market under the symbol “RIME.” The last reported sale price of our common stock on The Nasdaq Capital Market on September 29, 2025 was $2.61 per share.
Investing in our common stock involves a high degree of risk, including the risk of losing your entire investment. See “Risk Factors” beginning on page 9 of this prospectus for a discussion of information that should be considered in connection with an investment in our common stock.
Neither the Securities and Exchange Commission (“SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is , 2025
TABLE OF CONTENTS
| ABOUT THIS PROSPECTUS | ii |
|---|---|
| MARKET DATA | ii |
| PROSPECTUS SUMMARY | 1 |
| SUMMARY OF THE OFFERING | 8 |
| RISK FACTORS | 9 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS | 30 |
| USE OF PROCEEDS | 31 |
| SELLING STOCKHOLDER | 31 |
| SECURITIES ACT RESTRICTIONS ON RESALE OF COMMON STOCK | 33 |
| PLAN OF DISTRIBUTION | 33 |
| DIVIDEND POLICY | 34 |
| MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 35 |
| BUSINESS | 44 |
| MANAGEMENT | 46 |
| EXECUTIVE COMPENSATION | 51 |
| PRINCIPAL STOCKHOLDERS | 55 |
| CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS | 56 |
| DESCRIPTION OF CAPITAL STOCK | 58 |
| EXPERTS | 60 |
| LEGAL MATTERS | 60 |
| WHERE YOU CAN FIND MORE INFORMATION | 61 |
| INDEX TO FINANCIAL STATEMENTS | F-1 |
You should rely only on the information contained in this prospectus or any prospectus supplement or amendment. Neither we nor Streeterville have authorized any other person to provide you with information that is different from, or adds to, that contained in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. Neither we nor Streeterville take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should assume that the information contained in this prospectus or any free writing prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date. We are not making an offer of any securities in any jurisdiction in which such offer is unlawful.
We will not receive any proceeds from the sale by Streeterville of the common stock offered by it in this prospectus.
A prospectus supplement may also add, update or change information included in this prospectus. Any statement contained in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in such prospectus supplement modifies or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. You should rely only on the information contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. See “Where You Can Find More Information.”
This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described in the section entitled “Where You Can Find More Information.”
No action is being taken in any jurisdiction outside the United States to permit a public offering of our securities or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this public offering and the distribution of this prospectus applicable to that jurisdiction.
i
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.